Editing Quest Diagnostics (section)

==History==
[[File:Counter space at Quest Diagnostics in Franconia.jpg|thumb|left|Interior of a Patient Service Center in [[Franconia, Virginia]]]]

=== 1960–1995 ===
Originally founded as Metropolitan Pathology Laboratory, Inc. in 1967 by [[Paul A. Brown, MD]], the clinical laboratory underwent a variety of name changes.<ref>{{Cite news |url=https://www.northjersey.com/story/news/bergen/teterboro/2017/04/21/quest-diagnostics-celebrates-50-years/100691142/ |title=Quest Diagnostics celebrates 50 years |work=North Jersey|access-date=October 23, 2018}}</ref> In 1969, the company's name changed to MetPath, Inc.<ref>{{Cite news |url=https://www.theridgefieldpress.com/15093-a-raymond-bessette-82-investment-banker-built-skating-rink/ |title=A. Raymond Bessette, 82, investment banker, built skating rink |date=March 5, 2013 |work=The Ridgefield Press|access-date=October 23, 2018}}</ref> with headquarters in [[Teaneck, New Jersey]]. By 1982, MetPath was acquired by what was then known as [[Corning Glass Works]]<ref>{{Cite news |url=https://www.nytimes.com/1981/11/20/business/corning-glass-to-buy-metpath.html |title=Corning Glass To Buy Metpath|access-date=October 23, 2018 |work=The New York Times|date=November 20, 1981 }}</ref> and was subsequently renamed Corning Clinical Laboratories.<ref name=":0">{{Cite web |url=http://www.fundinguniverse.com/company-histories/quest-diagnostics-inc-history/ |title=History of Quest Diagnostics Inc. |publisher=FundingUniverse|access-date=October 23, 2018|archive-url=https://web.archive.org/web/20181023120305/http://www.fundinguniverse.com/company-histories/quest-diagnostics-inc-history/|archive-date=October 23, 2018}}</ref>

=== 1996–2000 ===
On December 31, 1996, Quest Diagnostics became an independent company as a [[Corporate spin-off|spin-off]] from [[Corning Incorporated|Corning]].<ref name=":0" /><ref>{{Cite news |url=https://www.nytimes.com/1996/11/28/business/corning-to-spin-off-2-subsidiaries-to-shareholders.html |title=Corning to Spin Off 2 Subsidiaries to Shareholders |agency=Reuters|access-date=October 31, 2018 |work=The New York Times|date=November 28, 1996 }}</ref> [[Kenneth W. Freeman]] was appointed as [[CEO]] during this transition.<ref>{{Cite web |url=https://bucknellian.net/81788/news/kenneth-w-freeman-college-management-named-25-million-donation/ |title=Kenneth W. Freeman college of management named after $25 million donation |work=The Bucknellian |last=Nicolai |first=Kathryn|access-date=October 31, 2018 |date=February 2018}}</ref><ref>{{Cite news |url=http://www.bu.edu/today/2010/kenneth-w-freeman-named-dean-of-smg/ |title=Kenneth W. Freeman Named Dean of SMG |work=BU Today |publisher=Boston University|access-date=October 31, 2018}}</ref> Over the next year, Quest acquired a clinical laboratory division of [[Branford, Connecticut]]–based Diagnostic Medical Laboratory, Inc. (DML).<ref>{{cite web |url=http://phx.corporate-ir.net/phoenix.zhtml?c=82068&p=irol-newsArticle&ID=199488&highlight= |title=Quest Diagnostics Acquires Assets Of Diagnostics Medical Laboratory Inc. |publisher=Quest Diagnostics |access-date=February 15, 2012}}</ref> Two years later in 1999, Quest added [[GlaxoSmithKline|SmithKline Beecham]] Clinical Laboratories to their subsidiaries;<ref>{{Cite news |url=https://seekingalpha.com/article/371261-investors-should-wait-out-quest-and-labcorp |title=Investors Should Wait Out Quest And LabCorp |last=Nouri |first=Paul |date=February 16, 2012 |work=Seeking Alpha|access-date=October 31, 2018}}</ref><ref>{{Cite news |url=https://hbr.org/2016/02/a-guide-to-being-compassionate-during-layoffs |title=A Guide to Being Compassionate During Layoffs |date=February 25, 2016 |work=Harvard Business Review|access-date=October 31, 2018}}</ref> which includes a joint venture ownership with CompuNet Clinical Laboratory.<ref>{{Cite web |url=https://www.bizjournals.com/dayton/news/2014/10/20/compunet-names-new-ceo.html |title=Compunet names new CEO |website=Dayton Business Journal |date=October 20, 2014|access-date=October 31, 2018}}</ref> The purchase of SmithKline Beecham also included the lab's medical sample transport airline {{Airline codes|<!--no iata-->|LBQ|LABQUEST}} originally founded in 1988.<ref>{{cite web |url=https://arstechnica.com/cars/2020/04/a-look-at-the-airline-that-flies-covid-19-samples-around-the-country/ |work=[[Ars Technica]] |first=Eric |last=Tegler |title=Appearing nightly, the Quest Diagnostics Air Force |date=April 29, 2020}}</ref>

In 1997, Quest and [[Banner Health]] formed a joint venture creating the Arizona based Sonora Quest laboratory, a business unit of Laboratory Sciences of Arizona.<Ref>{{cite web | url=https://www.sonoraquest.com/newsroom/posts/sonora-quest-laboratories-celebrates-20th-anniversary/ | title=Sonora Quest Laboratories Celebrates 20th Anniversary &#124; Newsroom }}</ref> This entity represents the operations of Quest Diagnostics in the Arizona regional market.

=== 2001–2015 ===
[[File:Steve Rusckowski at the World Economic Forum.jpg|thumb|Steve Rusckowski, the chairman, president, and CEO of Quest Diagnostics at the [[World Economic Forum]] in 2017]]
From May 2004 to April 2012, Surya Mohapatra served as the company's President and CEO. In 2007 Quest acquired diagnostic testing equipment company AmeriPath.<ref name="Reuters">{{Cite web |title=Quest Buying AmeriPath For $1.23 Billion |agency=Reuters |website=[[CNBC]]| access-date = February 4, 2019 |date=April 16, 2007 |url=https://www.cnbc.com/2007/04/16/quest-buying-ameripath-for-123-billion.html}}</ref> In response to Mohapatra's resignation after eight years with Quest, former Philips Healthcare CEO Stephen Rusckowski was appointed.<ref>{{cite web |url=https://www8.gsb.columbia.edu/cbs-directory/detail/snm2127= |title=Surya N. Mohapatra |publisher=Columbia Business Schools |access-date=March 31, 2018}}</ref> Under Rusckowski, Quest Diagnostics teamed up with central New England's largest health care system, [[UMass Memorial Health Care]], to purchase its clinical outreach laboratory.<ref>{{cite web |url=https://finance.yahoo.com/news/dgx-buy-umass-medical-lab-113034613.html |title=DGX to Buy UMass Medical Lab (revised) |date=October 23, 2012 |publisher=Yahoo! Finance|access-date=May 18, 2015}}</ref>

=== 2016–present ===
In 2016, Quest collaborated with [[Safeway Inc.|Safeway]] to bring testing services to twelve of its stores in California, Maryland, Virginia, Texas and Colorado.<ref>{{Cite news |url=https://www.supermarketnews.com/nonfood-pharmacy/safeway-quest-diagnostics-bring-testing-services-12-stores |title=Safeway, Quest Diagnostics bring testing services to 12 stores |date=June 15, 2016 |work=Supermarket News|access-date=October 23, 2018}}</ref>

By the end of 2017, Quest, in partnership with [[Walmart]], incorporated laboratory testing in about 15 of their locations in Texas and Florida.<ref>{{Cite web |url=https://www.pharmacist.com/article/walmart-partners-quest-diagnostics-bring-lab-testing-15-stores |title=Walmart partners with Quest Diagnostics to bring lab testing to 15 stores |website=pharmacist.com|access-date=November 7, 2018}}</ref>

In May 2018, the company announced it will become an in-network laboratory provider to [[UnitedHealthcare]] starting in 2019, providing access to 48 million plan members.<ref>{{Cite news |url=https://www.cnbc.com/2018/05/26/quest-and-labcorp-shares-surge-on-optimism-shrug-off-contract-losses.html |title=Here's why investors are cheering Quest and LabCorp losing their exclusive contracts |last=Coombs |first=Bertha |date=May 26, 2018 |publisher=CNBC|access-date=December 3, 2018}}</ref>

In September 2018, Quest moved its headquarters from Madison, where it was located since 2007, to [[Secaucus, New Jersey]].<ref>{{Cite news |url=https://www.roi-nj.com/2018/09/27/healthcare/for-murphy-quest-ribbon-cutting-is-example-of-what-can-be/ |title=For Murphy, Quest Diagnostics ribbon-cutting is example of what can be |date=September 27, 2018 |work=ROI-NJ|access-date=October 23, 2018}}</ref><ref>{{Cite news |url=https://www.nj.com/hudson/index.ssf/2016/06/quest_diagnostics_to_relocate_headquarters_to_seca.html |title=Quest Diagnostics to relocate headquarters to Secaucus |work=The Star-Ledger|access-date=October 23, 2018}}</ref>

In November 2018, Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing from home.<ref>{{Cite web |title=Quest Launches Patient-Initiated Testing to Address Changing Consumer Preferences |url=https://www.360dx.com/infectious-disease/quest-launches-patient-initiated-testing-address-changing-consumer-preferences|access-date=September 13, 2020 |website=360Dx |date=January 17, 2017 |language=en-us}}</ref><ref>{{Cite web |title=QuestDirect |url=https://www.360dx.com/resources/new-product/questdirect|access-date=September 13, 2020 |website=360Dx |date=November 7, 2018 |language=en-us}}</ref>

In March 2020, the company launched a [[COVID-19]] testing service.<ref>{{Cite web |last=Stankiewicz |first=Kevin |date=March 24, 2020 |title=Two large US private labs say they could soon process 300,000 coronavirus tests per week |url=https://www.cnbc.com/2020/03/24/coronavirus-labcorp-quest-diagnostics-are-growing-testing-capacity.html|access-date=August 19, 2020 |website=CNBC |language=en}}</ref> As of July 2020, Quest had performed more than 9.2 million COVID-19 molecular tests and 2.8 million serology tests.<ref>{{Cite web |date=July 28, 2020 |title=Quest Diagnostics addresses testing capacity and lengthy turnaround times |url=https://www.turnto23.com/news/coronavirus/quest-diagnostics-addresses-testing-capacity-and-lengthy-turnaround-times|access-date=August 19, 2020 |website=KERO |language=en}}</ref>

In April 2024, Quest has added a new blood screening to their AD-Detect product line. This test will analyze the blood for a specific Alzheimer's protein, pTau-217.<ref>{{Cite web |last=Hale |first=Conor |date=April 22, 2024 |title=Labcorp, Quest add new blood tests for Alzheimer's, brain tissue damage |url=https://www.fiercebiotech.com/medtech/labcorp-quest-add-new-blood-tests-alzheimers-brain-tissue-damage |access-date=April 23, 2024 |website=Fierce Biotech}}</ref>

In Febuaray 2025, [[Fresenius Medical Care]] announced via Helen Giza (CEO, Chair of the management board and acting CFO) that  "under terms of a definitive acquisition agreement, Quest will acquire select assets of FME’s wholly owned  Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S."

In addition, under a separate agreement, "Quest will provide comprehensive laboratory services related to end-stage kidney disease (ESKD) and specialized water testing for patients and providers served by dialysis centers operated by Fresenius Medical Care and its wholly owned and joint-venture partners in the United States."<ref>{{cite web | title=Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics | website=Fresenius Medical Care | date=Feb 25, 2025 | url=https://freseniusmedicalcare.com/en/media/newsroom/divestment-of-select-laboratory-assets-to-quest-diagnostics/?utm_source=marketo&utm_medium=email&utm_campaign=25feb2025_q4_financial_earnings&utm_content=allemployees&mkt_tok=OTU3LU5FTi0wNzAAAAGY2r3ewNz-EC-ZQLWgE2PTs1VtVVotNcCjO7nsFdksHR0m8M-tevcQ0g_CPwrc-zxEo2h7xsVf4QMs2HGHOOgB1pxhNVvT1XGIkDGVgPI2KNwgfw | ref={{sfnref|Fresenius Medical Care|2025}} | access-date=2025-02-25}}</ref>